The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Ho Carole since year 2005.
The trader's CIK number is 1724605.
At the time of this reporting, Ho Carole is the Chief Medical Officer of Denali Therapeutics Inc. .
(stock ticker symbol DNLI).
See this page for all insider trading activities at Denali Therapeutics Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-03||DNLI||Denali Therapeutics Inc.||Sale||17,500||18.80||328,930|
|2018-11-15||DNLI||Denali Therapeutics Inc.||Sale||17,500||18.07||316,155|
|2018-10-01||DNLI||Denali Therapeutics Inc.||Sale||17,500||21.72||380,100|
|2018-09-04||DNLI||Denali Therapeutics Inc.||Sale||17,500||19.05||333,375|
|2018-08-29||DNLI||Denali Therapeutics Inc.||Sale||17,500||18.04||315,700|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Carole (Chief Medical Officer of Denali Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.